293 related articles for article (PubMed ID: 15349798)
1. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Clin Rheumatol; 2005 Apr; 24(2):111-6. PubMed ID: 15349798
[TBL] [Abstract][Full Text] [Related]
2. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis.
Ihn H; Sato S; Fujimoto M; Takehara K; Tamaki K
Br J Rheumatol; 1998 Nov; 37(11):1188-92. PubMed ID: 9851267
[TBL] [Abstract][Full Text] [Related]
4. Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma.
Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):64-9. PubMed ID: 10607321
[TBL] [Abstract][Full Text] [Related]
5. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1.
Andersen GN; Caidahl K; Kazzam E; Petersson AS; Waldenström A; Mincheva-Nilsson L; Rantapää-Dahlqvist S
Arthritis Rheum; 2000 May; 43(5):1085-93. PubMed ID: 10817563
[TBL] [Abstract][Full Text] [Related]
6. Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.
Klimiuk PA; Sierakowski S; Domysławska I; Fiedorczyk M; Chwiećko J
Arch Immunol Ther Exp (Warsz); 2004; 52(1):36-42. PubMed ID: 15053231
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.
Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
Arthritis Res Ther; 2004; 6(4):R309-14. PubMed ID: 15225366
[TBL] [Abstract][Full Text] [Related]
8. [Serum soluble adhesion molecules--sICAM-1, sVCAM-1, sE-selectin--in patients with systemic rheumatoid arthritis].
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Pol Merkur Lekarski; 2004 Oct; 17(100):353-6. PubMed ID: 15690700
[TBL] [Abstract][Full Text] [Related]
9. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Ann Rheum Dis; 2002 Sep; 61(9):804-9. PubMed ID: 12176805
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels.
Mittag M; Beckheinrich P; Haustein UF
Acta Derm Venereol; 2001; 81(4):294-7. PubMed ID: 11720181
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients.
Cossu M; Andracco R; Santaniello A; Marchini M; Severino A; Caronni M; Radstake T; Beretta L
Rheumatology (Oxford); 2016 Jun; 55(6):1112-6. PubMed ID: 26989111
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
[TBL] [Abstract][Full Text] [Related]
13. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis.
Denton CP; Bickerstaff MC; Shiwen X; Carulli MT; Haskard DO; Dubois RM; Black CM
Br J Rheumatol; 1995 Nov; 34(11):1048-54. PubMed ID: 8542206
[TBL] [Abstract][Full Text] [Related]
14. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis.
Blann AD; Herrick A; Jayson MI
Br J Rheumatol; 1995 Sep; 34(9):814-9. PubMed ID: 7582719
[TBL] [Abstract][Full Text] [Related]
15. Elevation of serum soluble E-selectin and VCAM-1 in severe asthma.
Hamzaoui A; Ammar J; El Mekki F; Borgi O; Ghrairi H; Ben Brahim M; Hamzaoui K
Mediators Inflamm; 2001 Dec; 10(6):339-42. PubMed ID: 11817675
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of circulating vascular endothelial growth factor and soluble adhesion molecules as reliable predictors of native arteriovenous fistula thrombosis in chronic hemodialysis patients.
Zohny SF; Abd el-Fattah M
Clin Biochem; 2008 Oct; 41(14-15):1175-80. PubMed ID: 18692491
[TBL] [Abstract][Full Text] [Related]
17. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M
Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638
[TBL] [Abstract][Full Text] [Related]
18. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.
Magro F; Araujo F; Pereira P; Meireles E; Diniz-Ribeiro M; Velosom FT
Dig Dis Sci; 2004 Aug; 49(7-8):1265-74. PubMed ID: 15387356
[TBL] [Abstract][Full Text] [Related]
19. Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients.
Ciołkiewicz M; Kuryliszyn-Moskal A; Klimiuk PA
Clin Rheumatol; 2010 Feb; 29(2):175-80. PubMed ID: 19907914
[TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of fractalkine and mobilisation of CD34
Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
